Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad spending rankings. Indeed, since September, they’d taken turns alternating between ...
In most years, a graph of annual local TV ad spending is about as predictable as an electrocardiogram of a reasonably healthy patient in a doctor’s office. Revenue spikes upwards on even-numbered ...
When a TV commercial makes people feel something, it doesn’t just win in the moment – it sparks curiosity, drives searches, and fuels conversions. That’s why the “Breaking TV Ads Report,” jointly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results